- Home
- MYSZ vs SCNI Comparison
MYSZ vs SCNI Comparison
Compare MYSZ & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYSZ
- SCNI
- Stock Information
- Founded
- MYSZ 1999
- SCNI 2003
- Country
- MYSZ Israel
- SCNI Israel
- Employees
- MYSZ N/A
- SCNI N/A
- Industry
- MYSZ Computer Software: Prepackaged Software
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MYSZ Technology
- SCNI Health Care
- Exchange
- MYSZ Nasdaq
- SCNI Nasdaq
- Market Cap
- MYSZ 2.9M
- SCNI 1.9M
- IPO Year
- MYSZ N/A
- SCNI N/A
- Fundamental
- Price
- MYSZ $1.28
- SCNI $2.80
- Analyst Decision
- MYSZ Strong Buy
- SCNI
- Analyst Count
- MYSZ 1
- SCNI 0
- Target Price
- MYSZ $3.00
- SCNI N/A
- AVG Volume (30 Days)
- MYSZ 163.8K
- SCNI 22.4K
- Earning Date
- MYSZ 05-19-2025
- SCNI 07-01-2025
- Dividend Yield
- MYSZ N/A
- SCNI N/A
- EPS Growth
- MYSZ N/A
- SCNI N/A
- EPS
- MYSZ N/A
- SCNI 5.95
- Revenue
- MYSZ $8,257,000.00
- SCNI $658,000.00
- Revenue This Year
- MYSZ $29.71
- SCNI N/A
- Revenue Next Year
- MYSZ N/A
- SCNI N/A
- P/E Ratio
- MYSZ N/A
- SCNI $0.47
- Revenue Growth
- MYSZ 18.02
- SCNI N/A
- 52 Week Low
- MYSZ $1.01
- SCNI $1.90
- 52 Week High
- MYSZ $9.40
- SCNI $8.92
- Technical
- Relative Strength Index (RSI)
- MYSZ 46.43
- SCNI 57.37
- Support Level
- MYSZ $1.21
- SCNI $2.64
- Resistance Level
- MYSZ $1.61
- SCNI $2.69
- Average True Range (ATR)
- MYSZ 0.11
- SCNI 0.21
- MACD
- MYSZ -0.00
- SCNI 0.09
- Stochastic Oscillator
- MYSZ 30.19
- SCNI 84.27
About MYSZ My Size Inc.
My Size Inc is a USA-based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers and licensing cloud-enabled software subscriptions, associated software maintenance, and support.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.